Maze Therapeutics CSBO Sells: Reading Insider Moves
When a senior executive at Maze Therapeutics sells a stake after positive trial data and solid quarterly results, inv...
Building wealth without taking high risks is achievable with the right strategies. Explore options that prioritize safety and growth.
27,007 articlesWhen a senior executive at Maze Therapeutics sells a stake after positive trial data and solid quarterly results, inv...
The Navy's new 30-year shipbuilding plan calls for 15 Trump-Class battleships by 2055, with per-ship costs near $14.5...
A major Polymarket crisis unfolds as dozens of bets on geopolitical events remain unresolved. Oracle risk surfaces as...
Vitalik Buterin announced a recalibration of the Ethereum Foundation's role, underscoring a shift toward a smaller, p...
Uber is moving ride booking from the curb to the front desk, partnering with Mews to embed Uber rides directly into h...
Bank of America Global Research argues the housing crisis is driven by years of underbuilding and local policy barrie...
Retail prices rose in May, pushing inflation to a multi-year high as gas costs surged. The data raise questions for h...
When an IPO plunges, investors face a tough choice. This guide explains how to evaluate a stock that is down 84% and ...
Trump calls on Congress to codify a permanent 15% ethanol blend in gasoline, a move aimed at easing prices and streng...
AI data centers are driving a new energy challenge as grid bottlenecks stall growth. Off-grid, flameless generators a...
Only a small slice of workers over 50 tap catch-up contributions in 2026, even with higher limits. Inflation, housing...
Tensions in the Middle East pushed mortgage rates higher, but U.S. homebuyers pressed on. A weekly tracker shows dema...